| Literature DB >> 28149441 |
Kofi Mensah Nyarko1, Donne Kofi Ameme2, Dennis Ocansey3, Efua Commeh3, Mehitabel Tori Markwei4, Sally-Ann Ohene5.
Abstract
INTRODUCTION: Non-communicable diseases (NCDs) continue to pose threats to human health and development worldwide. Though preventable, NCDs kill more people annually than all other diseases combined. The four major NCDs namely cardiovascular diseases, chronic respiratory diseases, diabetes and cancers share common modifiable risk factors. In order to prevent and control NCDs, Ghana has adopted the World Health Organisation Package for Essential NCD (WHO-PEN) intervention, to be piloted in selected districts before a nationwide scale-up. We assessed the capacity of these facilities for the implementation of the WHO-PEN pilot.Entities:
Keywords: Capacity assessment; Ghana; Non-Communicable Diseases; WHO-PEN
Mesh:
Year: 2016 PMID: 28149441 PMCID: PMC5257011 DOI: 10.11604/pamj.supp.2016.25.1.6252
Source DB: PubMed Journal: Pan Afr Med J
Characteristics of the surveyed health facilities, Ghana, 2013
| Characteristics | Facility Type | |||
|---|---|---|---|---|
| CHPS | Health Centre | District Hospital | Regional Hospital | |
| n = 9 | n = 9 | n = 3 | n = 2 | |
| Public | 9 | 8 | 1 | 2 |
| Private | 0 | 0 | 1 | 0 |
| Quasi- government | 0 | 1 | 1 | 0 |
| Rural | 9 | 7 | 0 | 0 |
| Urban | 0 | 2 | 3 | 2 |
Availability of basic equipment in surveyed health facilities, Ghana, 2013
| Equipment | Health Facility Type | |||
|---|---|---|---|---|
| CHPS | Health Centre | District Hospital | Regional Hospital | |
| n (%) | n (%) | n (%) | n (%) | |
| Functional oxygen cylinder | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Functional BPMD | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
| Functional weighing scale | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
| Functional Glucometer | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Functional Nebulizer | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Functional Spacer | 00.0) | 0(0.0) | 0(0.0) | 0(0.0) |
| Functional Peak Flow Meter | 0(0.0) | 0(0.0) | 1(33.3) | 2(100.0) |
| Functional Pulse oxymeter | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Functional Health education materials | 1(11.1) | 5(55.6) | 2(66.7) | 2(100.0) |
| Functional tape measures | 6(66.7) | 9(100.0) | 3(100.0) | 2(100.0) |
| Functional ECG | 0(0.0) | 0(0.0) | 2(66.7) | 2(100.0) |
| Functional Stethoscopes | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
| Functional Thermometers | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
Availability of basic diagnostic tests in surveyed health facilities, Ghana, 2013
| Diagnostic Test | Health Facility Type | |||
|---|---|---|---|---|
| CHPS | Health Centre | District Hospital | Regional Hospital | |
| n(%) | n(%) | n(%) | n(%) | |
| Urine albumin/protein | 0(0.0) | 3(33.3) | 3(100.0) | 2(100.0) |
| Urine glucose | 0(0.0) | 3(33.3) | 3(100.0) | 2(100.0) |
| Urine ketones | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Blood glucose | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| SerumTroponin | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
| Blood cholesterol | 0(0.0) | 0(0.0) | 2(66.7) | 2(100.0) |
| Serum creatinine | 0(0.00 | 0(0.0) | 2(66.7) | 2(100.0) |
Availability of selected essential medicines in surveyed facilities, Ghana, 2013
| Selected Essential Medicine | Health Facility Type | |||
|---|---|---|---|---|
| CHPS | Health Centre | District Hospital | Regional Hospital | |
| n(%) | n(%) | n(%) | n(%) | |
| Adrenaline injection | 2(22.2) | 4(44.4) | 3(100.0) | 2(100.0) |
| Aspirin | 9(100.0) | 5(55.5) | 3(100.0) | 2(100.0) |
| Atenolol/Beta blockers | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Beclomethasone inhaler | 0(0.0) | 0(0.0) | 2(66.7) | 2(100.0) |
| Bendrofluazide | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Benzathine Penicillin | 5(55.6) | 6(66.7) | 3(100.0) | 2(100.0) |
| Enalapril/ Lisinopril | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Erythromycin | 9(100.0) | 3(33.3) | 3(100.0) | 2(100.0) |
| Furosemide | 0(0.0) | 3(33.3) | 3(100.0) | 2(100.0) |
| Glibenclamide | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Hydrocortisone (injection) | 8(88.9) | 8(88.9) | 3(100.0) | 2(100.0) |
| Insulin (long acting) | 0(0.0) | 0(0.0) | 2(66.7) | 2(100.0) |
| Insulin (soluble) | 0(0.0) | 0(0.0) | 3(100.0) | 2(100.0) |
| Ipratropium bromide | 0(0.0) | 0(0.0) | 0(0.0) | 1(50.0) |
| Isosorbidedinitrate | 0(0.0) | 0(0.0) | 2(66.7) | 2(100.0) |
| Statins | 0(0.0) | 0(0.0) | 1(33.3) | 2(100.0) |
| Metformin | 0(0.0) | 1(11.1) | 3(100.0) | 2(100.0) |
| Calcium channel blockers | 6(66.7) | 4(44.4) | 3(100.0) | 2(100.0) |
| Sodium chloride infusion | 7(77.8) | 9(100.0) | 3(100.0) | 2(100.0) |
| Phenoxymethyl Penicillin | 0(0.0) | 4(44.4) | 2(66.7) | 2(100.0) |
| Prednisolone | 1(11.1) | 3(33.3) | 3(100.0) | 2(100.0) |
| Salbutamol inhaler | 0(0.0) | 4(44.4) | 3(100.0) | 2(100.0) |
| Salbutamol tablet | 3(33.3) | 7(77.8) | 3(100.0) | 2(100.0) |
| Salbutamol injection | 0(0.0) | 0(0.0) | 2(66.7) | 2(100.0) |
| Paracetamol | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
| Ibuprofen | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
| Codeine | 0(0.0) | 0(0.0) | 1(33.3) | 2(100.0) |
| Morphine (oral) | 0(0.0) | 0(0.0) | 0(0.0) | 2(100.0) |
| Morpine (injection) | 0(0.0) | 0(0.0) | 1(33.3) | 2(100.0) |
| Glyceryltrinitrate | 0(0.0) | 0(0.0) | 0(0.0) | 2(100.0) |
| Heparin | 0(0.0) | 0(0.0) | 3(100.0) | 2(100.0) |
| Amoxycillin | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
| Cotrimoxazole | 9(100.0) | 9(100.0) | 3(100.0) | 2(100.0) |
| Promethazine injection | 7(77.8) | 7(77.8) | 3(100.0) | 2(100.0) |
| Glucose injectable | 7(77.8) | 8(88.9) | 3(100.0) | 2(100.0) |
Available means always or available within the last six months prior to the assessment